Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 625


A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model.

Kuklin NA, Clark DJ, Secore S, Cook J, Cope LD, McNeely T, Noble L, Brown MJ, Zorman JK, Wang XM, Pancari G, Fan H, Isett K, Burgess B, Bryan J, Brownlow M, George H, Meinz M, Liddell ME, Kelly R, Schultz L, Montgomery D, Onishi J, Losada M, Martin M, Ebert T, Tan CY, Schofield TL, Nagy E, Meineke A, Joyce JG, Kurtz MB, Caulfield MJ, Jansen KU, McClements W, Anderson AS.

Infect Immun. 2006 Apr;74(4):2215-23.


A fully human monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB) with functional activity in vitro and in vivo.

Ebert T, Smith S, Pancari G, Clark D, Hampton R, Secore S, Towne V, Fan H, Wang XM, Wu X, Ernst R, Harvey BR, Finnefrock AC, Wang F, Tan C, Durr E, Cope L, Anderson A, An Z, McNeely T.

Hum Antibodies. 2010;19(4):113-28. doi: 10.3233/HAB-2010-0235.


Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model.

Joshi A, Pancari G, Cope L, Bowman EP, Cua D, Proctor RA, McNeely T.

Hum Vaccin Immunother. 2012 Mar;8(3):336-46. doi: 10.4161/hv.18946. Epub 2012 Feb 13.


Protective efficacy of the chimeric Staphylococcus aureus vaccine candidate IC in sepsis and pneumonia models.

Yang L, Cai C, Feng Q, Shi Y, Zuo Q, Yang H, Jing H, Wei C, Zhuang Y, Zou Q, Zeng H.

Sci Rep. 2016 Feb 11;6:20929. doi: 10.1038/srep20929.


Characterization of the mechanism of protection mediated by CS-D7, a monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB).

Pancari G, Fan H, Smith S, Joshi A, Haimbach R, Clark D, Li Y, Hua J, McKelvey T, Ou Y, Drummond J, Cope L, Montgomery D, McNeely T.

Front Cell Infect Microbiol. 2012 Mar 20;2:36. doi: 10.3389/fcimb.2012.00036. eCollection 2012.


Evaluation of the protective immunity of a novel subunit fusion vaccine in a murine model of systemic MRSA infection.

Zuo QF, Yang LY, Feng Q, Lu DS, Dong YD, Cai CZ, Wu Y, Guo Y, Gu J, Zeng H, Zou QM.

PLoS One. 2013 Dec 4;8(12):e81212. doi: 10.1371/journal.pone.0081212. eCollection 2013.


Protection of mice against Staphylococcus aureus infection by a recombinant protein ClfA-IsdB-Hlg as a vaccine candidate.

Delfani S, Mohabati Mobarez A, Imani Fooladi AA, Amani J, Emaneini M.

Med Microbiol Immunol. 2016 Feb;205(1):47-55. doi: 10.1007/s00430-015-0425-y. Epub 2015 Jul 9.


Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.

Li X, Wang X, Thompson CD, Park S, Park WB, Lee JC.

MBio. 2016 Feb 2;7(1):e02232-15. doi: 10.1128/mBio.02232-15.


Human antibody response during sepsis against targets expressed by methicillin resistant Staphylococcus aureus.

Lorenz U, Ohlsen K, Karch H, Hecker M, Thiede A, Hacker J.

FEMS Immunol Med Microbiol. 2000 Oct;29(2):145-53.


Improved protective efficacy of a chimeric Staphylococcus aureus vaccine candidate iron-regulated surface determinant B ( N 126- P 361) -target of RNAIII activating protein in mice.

Yu L, Wang N, Ma J, Tong C, Song B, Chi J, Ma G, Zhu Z, Cui Y.

Microbiol Immunol. 2013 Dec;57(12):857-64. doi: 10.1111/1348-0421.12106.


Cross-protective effect of a novel multi-antigen-chimeric vaccine against Streptococcus and Staphylococcus aureus infection in mice.

Yu L, Fan Z, Ma J, Tong C, Song B, Zhu Z, Cui Y.

J Med Microbiol. 2014 Dec;63(Pt 12):1732-40. doi: 10.1099/jmm.0.073593-0. Epub 2014 Oct 6.


Staphylococcus aureus vaccine against mastitis in dairy cows, composition and evaluation of its immunogenicity in a mouse model.

Leitner G, Lubashevsky E, Trainin Z.

Vet Immunol Immunopathol. 2003 Jun 20;93(3-4):159-67.


A Diagnostic Serum Antibody Test for Patients With Staphylococcus aureus Osteomyelitis.

Nishitani K, Beck CA, Rosenberg AF, Kates SL, Schwarz EM, Daiss JL.

Clin Orthop Relat Res. 2015 Sep;473(9):2735-49. doi: 10.1007/s11999-015-4354-2. Epub 2015 May 27.


Immunity induced by Staphylococcus aureus surface protein A was protective against lethal challenge of Staphylococcus aureus in BALB/c mice.

Yi SQ, Zhang XY, Yang YL, Yang Y, Liu SL, Fu L, Yu CM, Chen W.

Microbiol Immunol. 2012 Jun;56(6):406-10. doi: 10.1111/j.1348-0421.2012.00451.x.


Immune responses to a Staphylococcus aureus GapC/B chimera and its potential use as a component of a vaccine for S. aureus mastitis.

Perez-Casal J, Prysliak T, Kerro-Dego O, Potter AA.

Vet Immunol Immunopathol. 2006 Jan 15;109(1-2):85-97. Epub 2005 Sep 13.


Staphylococcus aureus FhuD2 is involved in the early phase of staphylococcal dissemination and generates protective immunity in mice.

Mishra RP, Mariotti P, Fiaschi L, Nosari S, Maccari S, Liberatori S, Fontana MR, Pezzicoli A, De Falco MG, Falugi F, Altindis E, Serruto D, Grandi G, Bagnoli F.

J Infect Dis. 2012 Oct 1;206(7):1041-9. doi: 10.1093/infdis/jis463. Epub 2012 Jul 24.


Staphylococcus aureus antigens and challenges in vaccine development.

Middleton JR.

Expert Rev Vaccines. 2008 Aug;7(6):805-15. doi: 10.1586/14760584.7.6.805. Review.


Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen.

McKenney D, Pouliot KL, Wang Y, Murthy V, Ulrich M, Döring G, Lee JC, Goldmann DA, Pier GB.

Science. 1999 May 28;284(5419):1523-7.


Immunisation With Immunodominant Linear B Cell Epitopes Vaccine of Manganese Transport Protein C Confers Protection against Staphylococcus aureus Infection.

Yang HJ, Zhang JY, Wei C, Yang LY, Zuo QF, Zhuang Y, Feng YJ, Srinivas S, Zeng H, Zou QM.

PLoS One. 2016 Feb 19;11(2):e0149638. doi: 10.1371/journal.pone.0149638. eCollection 2016.

Supplemental Content

Support Center